The future of clinical development moves fast. Stay one step ahead by subscribing to our newsletter, The Protocol 🧬 AI x Clinical Trials. Every month, you'll receive: → Industry insights and thought leadership → Articles and research reports → Webinars and speaking sessions → Product updates and launches → Upcoming events, conferences, and key highlights 👉 Subscribe on our website or register through the footer form: https://lnkd.in/e5QdURkC #ClinicalTrials #AI #Biotech
About us
Our mission is to dramatically reduce the time and cost of clinical trials. Aika, our AI platform, supports the various stages of the clinical trial lifecycle Phase 1-3, up until market approval. Clinical trials can take 11 years and cost ∼$6.2B to bring a drug to market. 57% face costly protocol amendments that add months of delay. We're changing that. With Aika, users can generate compliant and comprehensive documents (feasibility studies, entire protocols, application forms, financial documents, consent forms etc.) within minutes. Aika features nearly 100% of clinical trials published in the past 25 years (1M+ trials from official registries), 260K+ clinical trial protocols, peer-reviewed articles, regulatory guidelines and many more. Every recommendation is backed by verifiable sources. Every decision stays with the clinical experts. Human oversight guaranteed. Faster trials don’t mean more risk. With Aika, they mean smarter science. The impact: → 50% faster protocol development → $200K-$400K saved per avoided amendment → Regulatory-ready outputs from day one Built by clinical experts, for clinical experts.
- Website
-
http://www.biorce.com
External link for Biorce
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Barcelona
- Type
- Privately Held
- Founded
- 2024
- Specialties
- Clinical Trials, Artificial Intelligence, Drug Development, Innovation, and StartUps
Locations
Employees at Biorce
Updates
-
The End. #conference #Barcelona | October 15 🤖 🧬 Clinical trials don't need another layer of complexity. They need solutions built for the trials actually running today. This one-day conference will gather experts interested in exploring AI-powered solutions that reduce costs and accelerate timelines: → Clinical development leaders → Scientists specialized on drug development → Innovators scoping out AI in clinical trial development → Executives from Pharma, Biotech, and CROs in search of input and latest developments And anyone interested in big data and automations for clinical trial efficiency. 📍 Espai Diagonal 📆 October 15 Secure your spot for #TheEndBarcelona2026 → https://lnkd.in/eBPz9Tgk #Barcelona #clinicaldevelopment #conference #AIinhealthcare #healthtech #AI
-
-
🤖🧬For 20 years, SaaS was the default thesis for growth investors. Today, AI is changing the rules, and firms are redefining their criteria month by month. “𝘛𝘩𝘦 𝘲𝘶𝘦𝘴𝘵𝘪𝘰𝘯 𝘪𝘴 𝘸𝘩𝘪𝘤𝘩 𝘤𝘰𝘮𝘱𝘢𝘯𝘪𝘦𝘴 𝘸𝘪𝘭𝘭 𝘣𝘦 𝘣𝘦𝘯𝘦𝘧𝘪𝘵𝘦𝘥 𝘣𝘺 𝘈𝘐 𝘢𝘯𝘥 𝘯𝘰𝘵 𝘥𝘪𝘴𝘳𝘶𝘱𝘵𝘦𝘥 𝘣𝘺 𝘈𝘐?" In the latest episode of #TheEndTalks, our CEO Pedro Coelho sits down with Anne-Charlotte Philbert, Managing Director at Eurazeo Growth to discuss about: → Venture capital and investment decisions in an AI-driven landscape → The investor perspective on AI-native versus traditional SaaS businesses → Why Europe is well positioned to compete in AI → How AI-native companies are building their own markets and transforming entire sectors 🎧 Full conversation here on Spotify: https://lnkd.in/e7AraeiE 🎥 Watch it now on YouTube: https://lnkd.in/etCEwAzi #Growth #Saas #AI #ClinicalTrials #Pharma #Healthcare
-
🤖 🧬 A room built for direct conversations and real solutions. That's what stayed with Jessica McKenzie, VP of Life Sciences at 2020 Onsite, after our last conference on AI x #clinicaltrials. We're building that room again at #TheEndBarcelona2026. 📍 Barcelona 📆 October 15 Join us 👉 https://lnkd.in/eBPz9Tgk
-
Earlier this year, we were honored to be named #4YFN26 Award winner, selected from a global pool led by investors and industry leaders. 🏆 🚀 The 4YFN Awards, held in partnership with the GSMA Foundry, spotlight the most promising digital startups and we were absolutely honored to be recognized in this edition! 📑 Now, we’re excited to see our story featured in a case study on the GSMA Foundry platform. Access the full case study here 👉 https://lnkd.in/e5C4Yaef
-
-
WE'RE HIRING! 🚀🔥 At Biorce, we’re working to make AI-driven clinical trials the new standard, and we're looking for talented people to join us. We’re growing across all teams and locations: → Lead Data Engineer - Barcelona → AI Engineer - Austin → Senior Clinical Specialist - Barcelona → VP of Business Development - New York 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗮𝗹𝗹 𝗼𝗽𝗲𝗻 𝗿𝗼𝗹𝗲𝘀 𝗻𝗼𝘄 📩 https://lnkd.in/eYbVZFYs Help us spread the word! Repost or tag someone for their next big challenge💥 #Hiring #HiringNow #Austin #Barcelona #NewYork
-
In the latest episode of #TheEndTalks, our CEO Pedro Coelho sits down with Anne-Charlotte Philbert, Managing Director at Eurazeo, to discuss how they're recalibrating their investment approach in the age of AI. "𝘞𝘦'𝘳𝘦 𝘳𝘦𝘥𝘦𝘧𝘪𝘯𝘪𝘯𝘨 𝘸𝘩𝘦𝘳𝘦 𝘸𝘦 𝘸𝘢𝘯𝘵 𝘵𝘰 𝘪𝘯𝘷𝘦𝘴𝘵, 𝘦𝘷𝘦𝘳𝘺 𝘮𝘰𝘯𝘵𝘩." Both are discussing, among other topics, 𝗵𝗼𝘄 𝗔𝗜 𝗶𝘀 𝗿𝗲𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝘃𝗲𝗻𝘁𝘂𝗿𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 and entrepreneurship compared to traditional SaaS businesses, and where companies need to adapt to stay competitive. 🎧 Coming soon on Spotify and YouTube. #Growth #AI #ClinicalTrials #Pharma #Healthcare
-
The End. #conference #Barcelona | October 15 🤖 🧬 Clinical trials are entering a new era, one that's taking shape in Barcelona this October. The people building, funding, and running the next chapter of clinical development are coming together at #TheEndBarcelona2026. 📍 Espai Diagonal 📆 Oct 15 Join us 👉 https://lnkd.in/eBPz9Tgk #TheEndBarcelona2026
-
🚀 We’re really excited to announce that we've been nominated for the 2026 #PrixGalien USA Awards for "Best Digital Health Solution" category! At Biorce, we’re driven by a clear mission: to dramatically reduce the time and cost of clinical trials so patients can benefit from life-saving treatments sooner. This nomination by The Galien Foundation means a new milestone on that journey. See you in New York! 🇺🇸 #PrixGalien #Innovation #ClinicalTrials #ClinicalDevelopment
𝗢𝗳𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗣𝗿𝗶𝘅 𝗚𝗮𝗹𝗶𝗲𝗻 𝟮𝟬𝟮𝟲 𝗻𝗼𝗺𝗶𝗻𝗲𝗲 𝘀𝗲𝗹𝗲𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗱! Winners of the Galien “Best of the Best” will be revealed October 29 in New York City. Read the full press release: https://prn.to/4g3sQgh
-
-
The End. #conference #Barcelona | October 15 🤖 🧬 Clinical trials aren’t slowed by science. They’re slowed by amendments, site selection, and data reviews caught in weeks-long loops. The successor to outdated clinical trials is already here: purpose-built AI, continuous oversight, and decisions made in days instead of months. 𝐓𝐡𝐞 𝐄𝐧𝐝. 𝐎𝐟 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 𝐚𝐬 𝐰𝐞 𝐤𝐧𝐞𝐰 𝐭𝐡𝐞𝐦. 📍 Espai Diagonal 📆 October 15 Secure your spot at #TheEndBarcelona2026 👉 https://lnkd.in/eBPz9Tgk
-